Prof. Dr. Erdal Belen
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Heart Failure 4 publicationsSource: OpenAlex / PubMed MeSHView publications
- Coronary Artery Disease 3 publications
- Mitral Valve Stenosis 3 publications
- Hypertension 3 publications
- Atrial Fibrillation 3 publications
- Non-ST Elevated Myocardial Infarction 2 publications
- Cardiomyopathies 2 publications
- Aortic Valve Stenosis 2 publications
- Heart Injuries 2 publications
- Rheumatic Heart Disease 2 publications
- Thrombosis 2 publications
- Vitamin D Deficiency 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyCardiologysaglik.gov.trFrom source
- Institutionİstanbul Haseki Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
- Area of workHeart FailureExtracted from 4 publications · Model version —From source
- Publications57 publicationsOpenAlex, Europe PMC, ORCIDFrom source
- ORCID0000-0003-1634-1750ORCIDFrom source
- Last synchronised5 November 2026 08:56https://hasekieah.saglik.gov.tr/TR-671576/doktorlar.html#erdal-belensaglik.gov.tr
Scientific work
Publications on Heart Failure
-
Diagnostic challenges in acute coronary syndrome: reconciling the STEMI–NSTEMI and OMI–NOMI paradigms
BMC Cardiovascular Disorders, 2026
DOI 10.1186/s12872-026-05612-3 PMID 41667977 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
26-CCC-16457-ACC A RARE CASE OF ANCA NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
Journal of the American College of Cardiology, 2026
DOI 10.1016/j.jacc.2026.02.3789 Source: OpenAlex
-
Complete versus culprit‑only revascularization in young STEMI patients with multivessel disease
Advances in Interventional Cardiology, 2026
DOI 10.5114/aic.2026.160032 PMID 42088968 Open-access full textSource: OpenAlex
-
Early Left Ventricular Function Following ACS Events in a Diverse Group of Patients Receiving Dapagliflozin or Empagliflozin for Type 2 Diabetes Mellitus
Bulletin of Cardiovasculer Academy, 2026
DOI 10.4274/kvbulten.galenos.2025.78941 Open-access full textSource: OpenAlex
-
Early changes in left ventricular mass index after empagliflozin initiation in type 2 diabetes: a retrospective cohort study
BMC Cardiovascular Disorders, 2026
DOI 10.1186/s12872-026-06694-9 Open-access full textSource: OpenAlex
-
Task-specific versus general-purpose AI models in ECG analysis: A comparative study with emergency medicine specialists
The American Journal of Emergency Medicine, 2025
DOI 10.1016/j.ajem.2025.06.068 PMID 40609173 6 citations (OpenAlex) Source: OpenAlex
-
The role of TyG index in predicting low left ventricular ejection fraction after acute coronary syndrome
Biomarkers in medicine, 2025
DOI 10.1080/17520363.2025.2485017 PMID 40156384 2 citations (Europe PMC) Open-access full textSource: Europe PMC
-
The impact of using SGLT-2 inhibitor on left ventricular longitudinal strain and NT-proBNP levels during six-month follow-up in diabetic patients with and without coronary artery disease with preserved ejection fraction
Kardiologia Polska, 2024
DOI 10.33963/v.phj.100613 PMID 38767161 10 citations (OpenAlex) Open-access full textSource: OpenAlex
-
The More Vulnerable, the More Fatal: Predictors for Mortality in Patients with Dreadful Infective Endocarditis
Flora the Journal of Infectious Diseases and Clinical Microbiology, 2024
DOI 10.5578/flora.2024031190 Open-access full textSource: OpenAlex
-
Which Factors Determine the Success of Anticoagulation with Warfarin
International Journal of Cardiovascular Practice, 2023
DOI 10.5812/intjcardiovascpract-140879 1 citation (OpenAlex) Open-access full textSource: ORCID